Search

Helpline: phone0300 0110 122

OxQuip – Oxford study of Quantification in Parkinsonism

OxQuip are looking for patients with Progressive Supranuclear Palsy to participate in a research study.


What would I have to do?

  • You would be invited to take part in a testing session lasting about an hour and a half to two hours, once every three months over 2 years.
  • All tests are completely non-invasive and painless
  • Testing sessions will take place at the University of Oxford, John Radcliffe Hospital in Oxford
  • We will reimburse you all your travel expenses.

What is the study about?

It is estimated that there are seven to ten million people with Parkinson’s and Progressive Supranuclear Palsy disease worldwide. Currently available treatments are symptomatic only, and while they may be very effective for a number of years, they do not have any preventive or disease-slowing effect. Potential new treatments are in the early stages of development and we wish to develop new ways of measuring Parkinson’s symptoms as precisely as possible so that when new drugs are ready to test, we are able to very accurately measure their effectiveness in clinical trials.

What will we ask you to do?

During the study, you will be asked to perform simple tasks while we measure the movements you are making with your eyes, hands and body.  We will also ask you to do some tasks on a tablet computer that measure cognitive performance.  After the clinic visit, we may give you some sensors to wear for up to a few days at home.  These will not get in the way of anything you normally do and are likely to be in the form of bracelets or patches applied to the skin.  To avoid any further inconvenience we will provide prepaid envelopes to post them back to us or offer to collect them from you. You are free to withdraw at any time, without giving a reason and this will not affect your future care in any way.

Interested?

If you would like to take part or you would like further information about the study please get in touch with Professor Chrystalina Antoniades on 01865 234 728, Chrystalina.antoniades@ndcn.ox.ac.uk.

Initial findings from the…

Research estimates that up to 10,000 people may be living…

PASSPORT Study Discontinued

At the end of last week pharmaceutical company Biogen announced…

Help us identify the…

This month PSPA launched its first study to identify the…

New online interactive resource

We are thrilled to launch our new online interactive resource…